SHL to showcase latest innovations at PDA Universe of Pre-Filled Syringes & Injection Devices

20170913 Home Page Bg 800x580

SHL Group is to present its range of new devices and innovative technologies at the 2017 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices.

At the center of this exhibition are designs for high volume and high viscosity formulations. SHL will debut the ground-breaking Maggie®, a two-step cartridge-based solution for high-volume injections and Needle Isolation Technology (NIT®), designed to prevent metal leachables from contaminating the drug product. Also on display are the Bertha®, an autoinjector that features a continuous clicking mechanism to enhance usability and safety, and the Rotaject®, a cutting-edge constant force technology that allows for the delivery of highly viscous formulations of up to several hundred centipoise. SHL representatives would be happy to demonstrate these devices along with other services and capabilities available through SHL’s comprehensive network, including development, manufacturing, and commercialization solutions.

Corresponding with this year’s exhibition theme, “improving patients’ outcomes with innovative drug delivery,” SHL will also introduce its range of digital initiatives for digital health, connected technology, and therapy management. Representatives from renowned developers of advanced drug delivery systems will also be available to talk about the company’s comprehensive capabilities and commercialization solutions for faster time-to-market.

“The recent surge in biologics and biosimilars, along with the continuous need to improve treatment outcome and patient adherence, have made the need for innovative and intuitive delivery devices more evident than ever. SHL has a full range of solutions to meet that need. We’ll be in Vienna to meet pharma companies where they are and to help them take the next step,” said Magnus Fastmarken, the global marketing director of SHL Group.

Markus Bauss, the managing director of SHL Connect, will share his expertise in talks at a pre-conference workshop on November 6 as well as at the main event. At the conference, he will deliver a presentation titled “Injectable Drug Delivery – Rethinking Best Practice in Manufacturing Based on Smart Objects and Intelligent Machinery.”

The two-day exhibition will be held November 7-8 at the Austria Center in Vienna, Austria. Visit SHL at Booth X73-75 to find out more about its drug delivery devices and comprehensive solutions.

About SHL

SHL Group is a world-leading solutions provider in the design, development, and manufacturing of advanced drug delivery devices such as autoinjectors, pen injectors and advanced inhaler systems. We also offer core competencies and services in the fields of medtech and patient care solutions. With locations in Taiwan, Switzerland, Sweden, China and the US, our experienced engineers and designers develop product enhancements as well as breakthrough drug delivery and patient care solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

With over 4,800 employees worldwide, SHL Group consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe.

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information, visit

Media contact:


Related News